Showing results (31-40 of 93) with videos related to
Sort By:
Pageof 10
European Journal of Medicinal Chemistry|June 12, 2010
Chiral preference of L-tryptophan derived metal-based antitumor agent of late 3d-metal ions (Co(II), Cu(II) and Zn(II)) in comparison to D- and DL-tryptophan analogues: their in vitro reactivity towards CT DNA, 5'-GMP and 5'-TMPFarukh Arjmand, Mohd Muddassir, Rizwan Hasan KhanRSC Advances|May 2, 2022
Evaluation of cytotoxic potential of structurally well-characterized RNA targeted ionic non-steroidal anti-inflammatory (NSAID) Cu(ii) & Zn(ii) DACH-mefenamato drug conjugates against human cancer cell linesHuzaifa Yasir Khan, Sartaj Tabassum, Farukh ArjmandSpectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|February 21, 2012
New modulated design and synthesis of chiral CuII/SnIV bimetallic potential anticancer drug entity: in vitro DNA binding and pBR322 DNA cleavage activitySartaj Tabassum, Girish Chandra Sharma, Farukh ArjmandChemical Record (New York, N.Y.)|February 10, 2023
Progress of Metal-Based Anticancer Chemotherapeutic Agents in Last two Decades and their Comprehensive Biological (DNA/RNA Binding, Cleavage and Cytotoxicity Activity) StudiesFarukh Arjmand, Huzaifa Yasir Khan, Sartaj TabassumBioorganic Chemistry|November 19, 2019
Structure elucidation {spectroscopic, single crystal X-ray diffraction and computational DFT studies} of new tailored benzenesulfonamide derived Schiff base copper(II) intercalating complexes: Comprehensive biological profile {DNA binding, pBR322 DNA cleavage, Topo I inhibition and cytotoxic activity}Zeenat Afsan, Thierry Roisnel, Sartaj Tabassum, et al.Dalton Transactions (Cambridge, England : 2003)|May 30, 2013
New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activitySartaj Tabassum, Mehvash Zaki, Mohd Afzal, et al.European Journal of Medicinal Chemistry|February 11, 2014
Synthesis and characterization of Cu(II)-based anticancer chemotherapeutic agent targeting topoisomerase Iα: in vitro DNA binding, pBR322 cleavage, molecular docking studies and cytotoxicity against human cancer cell linesSartaj Tabassum, Mehvash Zaki, Mohd Afzal, et al.Chirality|September 25, 2012
Enantiomeric specificity of biologically significant Cu(II) and Zn(II) chromone complexes towards DNAFarukh Arjmand, A Jamsheera, Mohd Afzal, et al.Journal of Biomolecular Structure & Dynamics|March 9, 2021
Deciphering the effect of hydrophobicity on protein binding interaction in cobalt(II) complexes by multispectroscopic and computational methodsMasrat Bashir, Imtiyaz Yousuf, Farukh Arjmand, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|October 24, 2009
Synthesis of new heterometallic macromolecules: their DNA binding, cleavage activity and in vitro model electrochemotherapy studySartaj Tabassum, Irshad-ul-Haq Bhat, Farukh ArjmandPageof 10